Contrast-Induced Nephropathy: Update on the Use of Crystalloids and Pharmacological Measures
Joint Authors
Patschan, Daniel
Buschmann, Ivo
Ritter, Oliver
Source
International Journal of Nephrology
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-8, 8 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-05-02
Country of Publication
Egypt
No. of Pages
8
Main Subjects
Abstract EN
Contrast-induced nephropathy (CIN) is a frequent and severe complication in subjects receiving iodinated contrast media for diagnostic or therapeutic purposes.
Several preventive strategies were evaluated in the past.
Recent clinical studies and meta-analyses delivered some new aspects on preventive measures used in the past and present.
We will discuss all pharmacological and nonpharmacological procedures.
Finally, we will suggest individualized recommendations for CIN prevention.
American Psychological Association (APA)
Patschan, Daniel& Buschmann, Ivo& Ritter, Oliver. 2018. Contrast-Induced Nephropathy: Update on the Use of Crystalloids and Pharmacological Measures. International Journal of Nephrology،Vol. 2018, no. 2018, pp.1-8.
https://search.emarefa.net/detail/BIM-1173645
Modern Language Association (MLA)
Patschan, Daniel…[et al.]. Contrast-Induced Nephropathy: Update on the Use of Crystalloids and Pharmacological Measures. International Journal of Nephrology No. 2018 (2018), pp.1-8.
https://search.emarefa.net/detail/BIM-1173645
American Medical Association (AMA)
Patschan, Daniel& Buschmann, Ivo& Ritter, Oliver. Contrast-Induced Nephropathy: Update on the Use of Crystalloids and Pharmacological Measures. International Journal of Nephrology. 2018. Vol. 2018, no. 2018, pp.1-8.
https://search.emarefa.net/detail/BIM-1173645
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1173645
